About AltMed Capital
AltMed Capital is a company based in Mississauga (Canada) founded in 2019 by Roger S McIntyre was acquired by Champignon Brands in April 2020. AltMed Capital operates in a competitive market with competitors including Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.
- Headquarter Mississauga, Canada
- Founders Roger S McIntyre
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Champignon Brands
(Apr 09, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AltMed Capital
Detailed funding history for AltMed Capital
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in AltMed Capital
AltMed Capital has secured backing from 1 investor. Prominent investors backing the company include Champignon Brands.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Psychedelic formulations for mental health treatment are developed.
|
Locked | Locked | Locked |
Investor details for AltMed Capital
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AltMed Capital
Investment portfolio details for AltMed Capital
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AltMed Capital
Detailed financials for AltMed Capital
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Altmed Capital Comparisons
Peer comparison for AltMed Capital
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AltMed Capital
AltMed Capital operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Suite solutions are provided for payers and healthcare providers.
|
|
| Locked | Locked | Locked |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| Locked | Locked | Locked |
Technology-based consultancy and product development services are provided.
|
|
| Locked | Locked | Locked |
Strategic consulting services are provided to life sciences companies.
|
Detailed competitors of AltMed Capital
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Altmed Capital
Complete news archive for AltMed Capital
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AltMed Capital
AltMed Capital was founded in 2019.
AltMed Capital is headquartered in Mississauga, Canada. It is registered at Mississauga, Ontario, Canada.
Roger S McIntyre is the current CEO of AltMed Capital. They have also founded this company.
AltMed Capital was established in 2019 in Mississauga, Canada, as a corporate advisory firm specializing in the medical sector. Guidance on strategic decisions, investments, and operations within healthcare and related industries is offered to clients. The firm is led by founder and CEO Roger S. McIntyre. Focus is maintained on North American markets, with services tailored to medical enterprises navigating regulatory and financial challenges.
AltMed Capital's top competitors include Indegene, Zuellig Pharma and IntegriChain.
AltMed Capital has 1 investor. Key investors include Champignon Brands.